T-Cell Subsets Required for Intravesical BCG Immunotherapy for Bladder Cancer
Author:
Affiliation:
1. From the Washington University School of Medicine, Department of Pathology and Division of Urology and The Jewish Hospital of St Louis, Department of Surgery, Division of Urology, St. Louis, Missouri
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference35 articles.
1. Experience with intravesical bacillus Calmette-Guerin therapy of superficial bladder tumors;Herr;Urology,1985
2. Bladder cancer immunotherapy;Lamm;J. Urol.,1982
3. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma;Brosman;J. Urol.,1982
4. A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional-cell carcinoma of the bladder;Lamm;New Engl. J. Med.,1991
5. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line;Pang;J. Urol.,1982
Cited by 236 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Seminal papers in urology: maintenance Bacillus Calmette-Guerin (BCG) immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study (SWOG-8507);BMC Urology;2023-11-24
2. The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition;Frontiers in Immunology;2023-08-31
3. Intratumoral PD1+CD38+Tim3+ CD8+ T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer;Cells;2023-07-26
4. Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2;Frontiers in Immunology;2023-07-13
5. Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin;Science Translational Medicine;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3